Beijing Leadman Biochemistry Co.,Ltd.

SZSE:300289 Stok Raporu

Piyasa değeri: CN¥2.7b

Beijing Leadman BiochemistryLtd Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Beijing Leadman BiochemistryLtd's earnings have been declining at an average annual rate of -5.1%, while the Biotechs industry saw earnings growing at 5.9% annually. Revenues have been growing at an average rate of 0.2% per year.

Anahtar bilgiler

-5.1%

Kazanç büyüme oranı

0.6%

EPS büyüme oranı

Biotechs Sektör Büyümesi11.3%
Gelir büyüme oranı0.2%
Özkaynak getirisi-0.1%
Net Marj-1.8%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Beijing Leadman Biochemistry Co.,Ltd.'s (SZSE:300289) 44% Price Boost Is Out Of Tune With Revenues

Oct 08
Beijing Leadman Biochemistry Co.,Ltd.'s (SZSE:300289) 44% Price Boost Is Out Of Tune With Revenues

A Look At The Fair Value Of Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289)

Apr 19
A Look At The Fair Value Of Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289)

Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289) Shares Fly 27% But Investors Aren't Buying For Growth

Mar 08
Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289) Shares Fly 27% But Investors Aren't Buying For Growth

Gelir ve Gider Dağılımı

Beijing Leadman BiochemistryLtd nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SZSE:300289 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 24403-718937
30 Jun 24423-119338
31 Mar 24448419537
31 Dec 234621519537
30 Sep 23504-6721632
30 Jun 23559-6422435
31 Mar 23623-6023334
01 Jan 23706-5623335
30 Sep 226922820337
30 Jun 226933319134
31 Mar 226402818733
01 Jan 225642218433
30 Sep 21561-2725631
30 Jun 21541-3125731
31 Mar 21531-2924437
31 Dec 20472-5123138
30 Sep 20478116843
30 Jun 20440-815647
31 Mar 20454-1517047
31 Dec 19515617948
30 Sep 19493-1019749
30 Jun 195631019745
31 Mar 196002819643
31 Dec 186554019640
30 Sep 187117816940
30 Jun 186637115255
31 Mar 186347514246
31 Dec 175767314437
30 Sep 175387915225
30 Jun 17532751720
31 Mar 17521681800
31 Dec 16533701810
30 Sep 166181261690
30 Jun 166391441750
31 Mar 166601601610
31 Dec 156821571670
30 Sep 156821411770
30 Jun 156411331660
31 Mar 156071311650
31 Dec 145371281490
30 Sep 14373801160
30 Jun 14363911090
31 Mar 14342991010
31 Dec 13344110930

Kaliteli Kazançlar: 300289 is currently unprofitable.

Büyüyen Kar Marjı: 300289 is currently unprofitable.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 300289 is unprofitable, and losses have increased over the past 5 years at a rate of 5.1% per year.

Büyüme Hızlandırma: Unable to compare 300289's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: 300289 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (0.08%).


Özkaynak Getirisi

Yüksek ROE: 300289 has a negative Return on Equity (-0.14%), as it is currently unprofitable.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin